A Phase 3, Randomized, Parallel-Group, Active-Controlled, Double-Blind Study to Compare the Efficacy and Safety of CT-P10 With MabThera, Each Administered in Combination With Cyclophosphamide, Vincristine, and Prednisone (CVP) in Patients With Advanced Follicular Lymphoma.
Phase of Trial: Phase III
Latest Information Update: 12 Oct 2013
At a glance
- Drugs Cyclophosphamide; Prednisolone; Rituximab; Vincristine
- Indications Follicular lymphoma
- Focus Pharmacogenomic; Registrational; Therapeutic Use
- Sponsors Celltrion
- 10 Aug 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
- 23 Jun 2012 Additional location (spain) added as reported by European Clinical Trials Database record.
- 17 Apr 2012 New trial record